The oncogenic role of hepatitis B virus

Recent Results in Cancer Research

Volumn 193, Issue , 2014, Pages 59-74

  Rivière, Lise ^b   Ducroux, Aurélie ^b   Buendia, Marie Annick ^a  

^a INSERM   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

Epigenetic; Genetic; HBx; Hepatocellular carcinoma; Inflammation; Liver disease; Transcription

Indexed keywords

DOUBLE STRANDED DNA; HEPATITIS B VIRUS X PROTEIN; UBIQUITIN PROTEIN LIGASE E3; VIRUS DNA; TRANSACTIVATOR PROTEIN;

ARTICLE; DISEASE ASSOCIATION; DNA INTEGRATION; DNA METHYLATION; DNA REPAIR; DNA SEQUENCE; GENE MUTATION; GENOTYPE; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STABILITY; TRANSACTIVATION; VIRUS CARCINOGENESIS; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSCRIPTION; CANCER PROGNOSIS; CELL PROLIFERATION; CHRONIC HEPATITIS B; CYTOPATHOGENIC EFFECT; EPIGENETICS; GENE PRODUCT; HEPATITIS; HEPATITIS B VIRUS; IMMUNE RESPONSE; LIVER CARCINOGENESIS; LIVER CELL; MALIGNANT TRANSFORMATION; PLEIOTROPY; PROMOTER REGION; TRANSCRIPTION REGULATION; TUMOR VIRUS; VIRUS CELL TRANSFORMATION; VIRUS GENE; VIRUS PATHOGENESIS; X GENE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS;

EID: 84958542089     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-38965-8_4     Document Type: Article

References (93)

1. Andrisani OM, Barnabas S (1999) The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis. Int J Oncol 15:373-3799
2. Barry M, Fruh K (2006) Viral modulators of cullin RING ubiquitin ligases: culling the host defense. Sci STKE 335:211
3. Bartenschlager R, Schaller H (1992) Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral genome. EMBO J 11:3413-34200
4. Beasley RP, Lin CC, Hwang LY et al (1981) Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet 2:1129-11333
5. Becker SA, Lee TH, Butel JS et al (1998) Hepatitis B virus X protein interferes with cellular DNA repair. J Virol 72:266-2722
6. Belloni L, Pollicino T, De Nicola F et al (2009) Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc Natl Acad Sci U S A 106:19975-199799
7. Benhenda S, Cougot D, Buendia MA et al (2009a) Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis. Adv Cancer Res 103:75-1099
8. Benhenda S, Cougot D, Neuveut C et al (2009b) Liver cell transformation in chronic HBV infection. Viruses 1:630-6466
9. Bergametti F, Sitterlin D, Transy C (2002) Turnover of hepatitis B virus X protein is regulated by damaged DNA-binding complex. J Virol 76:6495-65011
10. Bonilla Guerrero R, Roberts LR (2005) The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma. J Hepatol 42:760-7777
11. Bontron S, Lin-Marq N, Strubin M (2002) Hepatitis B virus X protein associated with UV-DDB11 induces cell death in the nucleus and is functionally antagonized by UV-DDB2. J Biol Chem 277:38847-388544
12. Bouchard MJ, Schneider RJ (2004) The enigmatic X gene of hepatitis B virus. J Virol 78:12725-127344
13. Boyault S, Rickman DS, de Reynies A et al (2007) Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 45:42-522
14. Brechot C (2004) Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 127:S56-S611
15. Bréchot C, Pourcel C, Louise A et al (1980) Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 286:533-5355
16. Bruss V (2007) Hepatitis B virus morphogenesis. World J Gastroenterol 13:65-733
17. Chami M, Gozuacik D, Saigo K et al (2000) Hepatitis B virus-related insertional mutagenesis implicates SERCA1 gene in the control of apoptosis. Oncogene 19:2877-28866
18. Cheong J, Yi M, Lin Y et al (1995) Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO J 14:143-1500
19. Cougot D, Allemand E, Riviere L et al (2012) Inhibition of PP1 phosphatase activity by HBx: a mechanism for the activation of hepatitis B virus transcription. Sci Signal 5(250):ra11
20. Cougot D, Wu Y, Cairo S et al (2007) The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription. J Biol Chem 282:4277-42877
21. Doitsh G, Shaul Y (2004) Enhancer I predominance in hepatitis B virus gene expression. Mol Cell Biol 24:1799-18088
22. El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142(1264-1273):e12611
23. Fallot G, Neuveut C, Buendia MA (2012) Diverse roles of hepatitis B virus in liver cancer. Curr Opin Virol available online (in press)
24. Ferlay HR, Shin J, Bray F., et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127. 2893-29177
25. Fernandez AF, Rosales C, Lopez-Nieva P et al (2009) The dynamic DNA methylomes of doublestranded DNA viruses associated with human cancer. Genome Res 19:438-4511
26. Fujimoto A, Totoki Y, Abe T et al (2012) Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet 44:760-7644
27. Gottlob K, Pagano S, Levrero M et al (1998) Hepatitis B virus X protein transcription activation domains are neither required nor sufficient for cell transformation. Cancer Res 58:3566-35700
28. Guichard C, Amaddeo G, Imbeaud S et al (2012) Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 44:694-6988
29. He YJ, McCall CM, Hu J et al (2006) DDB1 functions as a linker to recruit receptor WD400 proteins to CUL4-ROC1 ubiquitin ligases. Genes Dev 20:2949-29544
30. Hodgson AJ, Hyser JM, Keasler VV et al (2012) Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replication. Virology 426:73-822
31. Höhne M, Schaefer S, Seifer M et al (1990) Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J 9:1137-11455
32. Huo TI, Wang XW, Forgues M et al (2001) Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis. Oncogene 20:3620-36288
33. Jackson S, Xiong Y (2009) CRL4 s: the CUL4-RING E3 ubiquitin ligases. Trends Biochem Sci 34:562-5700
34. Keasler VV, Hodgson AJ, Madden CR et al (2007) Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo. J Virol 81:2656-26622
35. Kim CM, Koike K, Saito I et al (1991) HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351:317-3200
36. Kim S, Park SY, Yong H et al (2008) HBV X protein targets hBubR1, which induces dysregulation of the mitotic checkpoint. Oncogene 27:3457-34644
37. Kumar V, Jayasuryan N, Kumar R (1996) A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function. Proc Natl Acad Sci USA 93:5647-56522
38. Lee TH, Elledge SJ, Butel JS (1995) Hepatitis B virus X protein interacts with a probable DNA repair protein. J Virol 69:1107-11144
39. Leupin O, Bontron S, Schaeffer C et al (2005) Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death. J Virol 79:4238-42455
40. Leupin O, Bontron S, Strubin M (2003) Hepatitis B virus X protein and simian virus 5 V protein exhibit similar UV-DDB1 binding properties to mediate distinct activities. J Virol 77:6274-62833
41. Li SK, Ho SF, Tsui KW et al (2008) Identification of functionally important amino acid residues in the mitochondria targeting sequence of hepatitis B virus X protein. Virology 381:81-888
42. Li T, Robert EI, van Breugel PC et al (2010) A promiscuous alpha-helical motif anchors viral hijackers and substrate receptors to the CUL4-DDB1 ubiquitin ligase machinery. Nat Struct Mol Biol 17:105-1111
43. Lin Y, Nomura T, Yamashita T et al (1997) The transactivation and p53-interacting functions of hepatitis B virus X protein are mutually interfering but distinct. Cancer Res 57:5137-51422
44. Lin-Marq N, Bontron S, Leupin O et al (2001) Hepatitis B virus X protein interferes with cell viability through interaction with the p127-kDa UV-damaged DNA-binding protein. Virology 287:266-2744
45. Liu S, Zhang H, Gu C et al (2009) Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst 101:1066-10822
46. Lizzano RA, Yang B, Clippinger AJ et al (2011) The C-terminal region of the hepatitis B virus X protein is essential for its stability and function. Virus Res 155:231-2399
47. Lucifora J, Arzberger S, Durantel D et al (2011) Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. J Hepatol 55:996-10033
48. Luo N, Cai Y, Zhang J et al (2012) The C-terminal region of the hepatitis B virus X protein is required for its stimulation of HBV replication in primary mouse hepatocytes. Virus Res 165:170-1788
49. Ma NF, Lau SH, Hu L et al (2008) COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis. Clin Cancer Res 14:5061-50688
50. Madden CR, Finegold MJ, Slagle BL (2001) Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions. J Virol 75:3851-38588
51. Maguire HF, Hoeffler JP, Siddiqui A (1991) HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 252:842-8444
52. Malmassari SL, Deng Q, Fontaine H et al (2007) Impact of hepatitis B virus basic core promoter mutations on T cell response to an immunodominant HBx-derived epitope. Hepatology 45:1199-12099
53. Martin-Lluesma S, Schaeffer C, Robert EI et al (2008) Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1. Hepatology 48:1467-14766
54. Mathonnet G, Lachance S, Alaoui-Jamali M et al (2004) Expression of hepatitis B virus X oncoprotein inhibits transcription-coupled nucleotide excision repair in human cells. Mutat Res 554:305-3188
55. Matsuzaki Y, Chiba T, Hadama T et al (1997) HBV genome integration and genetic instability in HBsAg-negative and anti-HCV-positive hepatocellular carcinoma in Japan. Cancer Lett 119:53-611
56. Moolla N, Kew M, Arbuthnot P (2002) Regulatory elements of hepatitis B virus transcription. J Viral Hepat 9:323-3311
57. Murakami S (1999) Hepatitis B virus X protein: structure, function and biology. Intervirology 42:81-999
58. Murakami Y, Saigo K, Takashima H et al (2005) Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 54:1162-11688
59. Ott JJ, Stevens GA, Groeger J et al (2012) Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30:2212-22199
60. Pagano JS, Blaser M, Buendia MA et al (2004) Infectious agents and cancer: criteria for a causal relation. Sem Cancer Biol 14:453-4711
61. Papatheodoridis GV, Lampertico P, Manolakopoulos S et al (2010) Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J Hepatol 53:348-3566
62. Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118:3030-30444
63. Pollicino T, Belloni L, Raffa G et al (2006) Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. Gastroenterology 130:823-8377
64. Poussin K, Dienes H, Sirma H et al (1999) Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas. Int J Cancer 80:497-5055
65. Raimondo G, Allain JP, Brunetto MR et al (2008) Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 49:652-6577
66. Rakotomalala L, Studach L, Wang WH et al (2008) Hepatitis B virus X protein increases the Cdt1-to-geminin ratio inducing DNA re-replication and polyploidy. J Biol Chem 283:28729-287400
67. Rui E, Moura PR, Goncalves Kde A et al (2005) Expression and spectroscopic analysis of a mutant hepatitis B virus onco-protein HBx without cysteine residues. J Virol Methods 126:65-744
68. Saigo K, Yoshida K, Ikeda R et al (2008) Integration of hepatitis B virus DNA into the myeloid/ lymphoid or mixed-lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma. Hum Mutat 29:703-7088
69. Scaglione SJ, Lok AS (2012) Effectiveness of hepatitis B treatment in clinical practice. Gastroenterology 142(1360-1368):e13611
70. Schaefer S (2005) Hepatitis B virus: significance of genotypes. J Viral Hepat 12:111-1244
71. Sirma H, Giannini C, Poussin K et al (1999) Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene 18:4848-48599
72. Sitterlin D, Bergametti F, Tiollais P et al (2000a) Correct binding of viral X protein to UVDDBp1277 cellular protein is critical for efficient infection by hepatitis B viruses. Oncogene 19:4427-44311
73. Sitterlin D, Bergametti F, Transy C (2000b) UVDDB p127-binding modulates activities and intracellular distribution of hepatitis B virus X protein. Oncogene 19:4417-44266
74. Sitterlin D, Lee TH, Prigent S et al (1997) Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient X-insertion mutants. J Virol 71:6194-61999
75. Soussan P, Garreau F, Zylberberg H et al (2000) In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA. J Clin Invest 105:55-600
76. Studach L, Wang WH, Weber G et al (2010) Polo-like kinase 1 activated by the hepatitis B virus X protein attenuates both the DNA damage checkpoint and DNA repair resulting in partial polyploidy. J Biol Chem 285:30282-302933
77. Studach LL, Rakotomalala L, Wang WH et al (2009) Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression. Hepatology 50:414-4233
78. Su Q, Schrôder CH, Hofman WJ et al (1998) Expression of hepatitis B virus X protein in HBVinfected human livers and hepatocellular carcinoma. Hepatology 27:1109-11200
79. Summers J, Smith PM, Huang M et al (1991) Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus. J Virol 65:1310-13177
80. Sung WK, Zheng H, Li S et al (2012) Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet 44:765-7699
81. Takahashi K, Akahane Y, Hino K et al (1998) Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Arch Virol 143:2313-23266
82. Tamori A, Yamanishi Y, Kawashima S et al (2005) Alteration of gene expression in human hepatocellular carcinoma with integrated hepatitis B virus DNA. Clin Cancer Res 11:5821-58266
83. Tang H, Delgermaa L, Huang F et al (2005) The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol 79:5548-55566
84. Terradillos O, Billet O, Renard CA et al (1997) The hepatitis B virus X gene potentiates c-mycinduced liver oncogenesis in transgenic mice. Oncogene 14:395-4044
85. Toh H, Hyashida H, Miyata T (1983) Sequence homology between retroviral reverse transcriptase and putative polymerases of hepatitis B virus and cauliflower mosaic virus. Nature 305:827-8299
86. Tu H, Bonura C, Giannini C et al (2001) Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res 61:7803-78100
87. Vivekanandan P, Thomas D, Torbenson M (2009) Methylation regulates hepatitis B viral protein expression. J Infect Dis 199:1286-12911
88. Wang HC, Huang W, Lai MD et al (2006) Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci 97:683-6888
89. Wang Q, Zhang T, Ye L et al (2012) Analysis of hepatitis B virus X gene (HBx) mutants in tissues of patients suffered from hepatocellular carcinoma in China. Cancer Epidemiol 36:369-3744
90. Wang WH, Studach LL, Andrisani OM (2011) Proteins ZNF198 and SUZ12 are down-regulated in hepatitis B virus (HBV) X protein-mediated hepatocyte transformation and in HBV replication. Hepatology 53:1137-11477
91. Wen Y, Golubkov VS, Strongin AY et al (2008) Interaction of hepatitis B viral oncoprotein with cellular target HBXIP dysregulates centrosome dynamics and mitotic spindle formation. J Biol Chem 283:2793-28033
92. Wentz MJ, Becker SA, Slagle BL (2000) Dissociation of DDB1-binding and transactivation properties of the hepatitis B virus X protein. Virus Res 68:87-922
93. Yeh CT, Shen CH, Tai DI et al (2000) Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma. Oncogene 19:5213-52200